Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -238.27% is 37% below its 5-year average of -173.65%, around the middle of its 5-year range (-349.10%–-73.12%).
12.87% below its 12-month average of -211.11%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2026 (2026-03-31): -46.43%.
RETURN ON ASSETS (ROA)
-238.27%
RETURN ON ASSETS (ROA) AVG TTM
-211.11%
RETURN ON ASSETS (ROA) AVG 3Y
-146.32%
RETURN ON ASSETS (ROA) AVG 5Y
-173.65%
RETURN ON ASSETS (ROA) AVG 10Y
-415.20%
RETURN ON ASSETS (ROA) AVG 15Y
-327.94%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-12.87%
CURRENT VS 3Y AVG
-62.84%
CURRENT VS 5Y AVG
-37.21%
CURRENT VS 10Y AVG
+42.61%
CURRENT VS 15Y AVG
+27.34%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-26.90%
median of 508 covered companies
CURRENT VS SECTOR MEDIAN
-785.76%
vs the sector median at left
BioRestorative Therapies, Inc.
Market Cap
$3.04M
Return on Assets (ROA)
-238.27%
TTM Avg
-211.11%
3Y Avg
-146.32%
5Y Avg
-173.65%
Market Cap
$3.07M
Return on Assets (ROA)
-80.08%
TTM Avg
-84.48%
3Y Avg
-250.02%
5Y Avg
-187.49%
Market Cap
$2.93M
Return on Assets (ROA)
-107.18%
TTM Avg
-105.74%
3Y Avg
-98.21%
5Y Avg
-95.08%
Market Cap
$2.75M
Return on Assets (ROA)
-199.30%
TTM Avg
-137.41%
3Y Avg
-109.57%
5Y Avg
-977.62%
Market Cap
$3.34M
Return on Assets (ROA)
-111.26%
TTM Avg
-147.41%
3Y Avg
-127.90%
5Y Avg
-106.52%
Market Cap
$3.36M
Return on Assets (ROA)
-95.33%
TTM Avg
-115.11%
3Y Avg
-93.94%
5Y Avg
-73.81%
Market Cap
$3.37M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.39M
Return on Assets (ROA)
-67.51%
TTM Avg
-41.84%
3Y Avg
-44.47%
5Y Avg
-41.13%
Market Cap
$2.62M
Return on Assets (ROA)
-154.47%
TTM Avg
-121.84%
3Y Avg
-88.87%
5Y Avg
-75.91%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.04M | -238.27% | -211.11% | -146.32% | -173.65% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -80.08% | -84.48% | -250.02% | -187.49% |
| Jaguar Health, Inc. (JAGX)vs › | $2.93M | -107.18% | -105.74% | -98.21% | -95.08% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.75M | -199.30% | -137.41% | -109.57% | -977.62% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.34M | -111.26% | -147.41% | -127.90% | -106.52% |
| IceCure Medical Ltd (ICCM)vs › | $3.36M | -95.33% | -115.11% | -93.94% | -73.81% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | -206.55% | -205.58% | -343.02% | -343.02% |
| Evogene Ltd. (EVGN)vs › | $3.39M | -67.51% | -41.84% | -44.47% | -41.13% |
| iSpecimen Inc. (ISPC)vs › | $2.62M | -154.47% | -121.84% | -88.87% | -75.91% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | -228.77% | -130.86% | -126.84% | -140.90% |
ROA
-238.3%
ROE
-365.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -349.10% |
| 2024-12-31 | -73.12% |
| 2023-12-31 | -82.60% |
| 2022-12-31 | -80.45% |
| 2021-12-31 | -197.31% |
| 2020-12-31 | -259.32% |
| 2019-12-31 | -998.95% |
| 2018-12-31 | -1049.82% |
| 2017-12-31 | -537.05% |
| 2016-12-31 | -546.60% |
| 2015-12-31 | -392.83% |
| 2014-12-31 | -330.28% |
| 2013-12-31 | -415.87% |
| 2012-12-31 | -515.50% |
| 2011-12-31 | -1843.64% |
| 2010-12-31 | -483.20% |
